Skip to main content
. Author manuscript; available in PMC: 2011 Oct 21.
Published in final edited form as: Future Oncol. 2010 Apr;6(4):551–562. doi: 10.2217/fon.10.11

Figure 3. Fatty acid synthase inhibitors.

Figure 3

(A) Cerulenin. (B) C75. (C) Orlistat. (D) GSK837149A. (E) AstraZeneca bisamide scaffold. (F) Merck hydroxyquinolin-2(1H)-one scaffold. (G) Platensimycin. (H) Epigallocatechin gallate analog.